Disease recurrence and progression in untreated pathologic stage T3 prostate cancer: Selecting the patient for adjuvant therapy

Journal of Urology

Volumn 158, Issue 4, 1997, Pages 1452-1456

  Lowe, Bruce A ^a   Lieberman, Stephen F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; DISEASE COURSE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0030775553     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64240-X     Document Type: Article

References (19)

1. Stamey, T. A., Villers, A. A., McNeal, J. E., Link, P. C. and Freiha, F. S.: Positive surgical margins at radical prostatectomy: importance of the apical dissection. J. Urol., 143: 1166, 1990.
2. Sole-Balcells, F., Villavicencio, H. and Ortiz, A.: Postsurgical management of the patient undergoing radical prostatectomy. Brit. J. Urol., suppl., 70: 43, 1992.
3. Haab, F., Boccon-Gibod, L., Delmas, V., Boccon-Gibod, L. and Toublanc, M.: Perineal versus retropubic prostatectomy for T1, T2 prostate cancer. Brit. J. Urol., 74: 626, 1994.
4. van den Ouden, D., Bentvelsen, F. M., Boeve, E. R. and Schroeder, F. H.: Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. Brit. J. Urol., 72: 489, 1993.
5. Zietman, A. L., Edelstein, R. A., Coen, J. J., Babayan, R. K. and Krane, R. J.: Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology, 43: 828, 1993.
6. Stein, A., deKernion, J. B. and Dorey, F.: Prostate specific antigen related to clinical status 1 to 14 years after radical prostatectomy. Brit. J. Urol., 67: 626, 1991.
7. Connolly, J. A., Shinohara, K., Presti, J. C., Jr. and Carroll, P. R.: Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology, 47: 225, 1996.
8. Anscher, M. S., Robertson, C. and Prosnitz, L. R.: Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten year update. Int. J. Rad. Oncol. Biol. Phys., 33: 37, 1995.
9. Eisbruch, A., Perez, C. A., Roessler, E. H. and Lockett, M. A.: Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer, 73: 384, 1994.
10. Meier, R., Mark, R., St. Royal, L., Tran, L., Colburn, G. and Parker, R.: Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer, 70: 1960, 1992.
11. Lerner, S. E., Blute, M. L. and Zincke, H.: Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J. Urol., 154: 1447, 1995.
12. Paulson, D. F., Moul, J. W. and Walther, P. J.: Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J. Urol., 144: 1180, 1990.
13. Paulson, D. F.: Impact of radical prostatectomy in the management of clinically localized disease. J. Urol., part 2, 152: 1826, 1994.
14. Foster, L. S., Jajodia, P., Fournier, G., Jr., Shinohara, K., Carroll, P. and Narayan, P.: The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J. Urol., 149: 1024, 1993.
15. Ferguson, J. K. and Oesterling, J. E.: Patient evaluation of prostate specific antigen that becomes elevated following radical prostatectomy or radiation therapy. Urol. Clin. N. Amer., 21: 677, 1994.
16. Trapasso, J. G., deKernion, J. B., Smith, R. B. and Dorey, F.: The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J. Urol., part 2, 152: 1821, 1994.
17. Epstein, J. I., Carmichael, M. J., Pizov, G. and Walsh, P. C.: Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J. Urol., 150: 135, 1993.
18. Norberg, M., Holmberg, L., Wheeler, T. and Magnusson, A.: Five year follow-up after radical prostatectomy for localized prostate cancer - a study of the impact of different tumor variables on progression. Scand. J. Urol. Nephrol., 28: 391, 1994.
19. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Schnall, M., Tomaszewski, J. E. and Wein, A.: A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J. Urol., 154: 131, 1995.